Sumi John

Bioinformatics Programmer - Computational Genetics & Genome Informatics Team at Dasman Diabetes Institute

Sumi John is a skilled bioinformatics programmer currently contributing to the Computational Genetics & Genome Informatics team at Dasman Diabetes Institute since February 2011. Prior to this role, Sumi worked as a visiting researcher at the University of Leeds from September 2010 to January 2011 and gained experience as an assistant systems engineer at Tata Consultancy Services between November 2007 and September 2009. Sumi holds a Master of Research degree in Bioinformatics & Computational Biology from the University of Leeds, obtained in 2010, and a Bachelor of Technology degree in Biotechnology & Biochemical Engineering from SCT College of Engineering, completed in 2007. Early education includes attending St. Thomas Central School in Trivandrum and Gulf Indian School.

Location

Al Asimah, Kuwait

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Dasman Diabetes Institute

Dasman Diabetes Institute (DDI) was established under the patronage of His Highness Sheikh Jaber Al Ahmed Al Sabah, the late Amir of the State of Kuwait, and the Kuwait Foundation for the Advancement of Sciences (KFAS) to combat the prevalence of diabetes in Kuwait. Since its inauguration in 2006 by His Highness Sheikh Sabah Al Ahmed Al Sabah (the late Amir of the State of Kuwait), the Institute has strived to address the diabetes epidemic in Kuwait through focused diabetes research, integrated prevention, training, and education. Through its Sectors, DDI aims to create a platform that applies its knowledge from basic sciences to clinical trial point of care applications, scientific findings, and drug discoveries, or from bench-to-bed. Our Operations Sector manages service performance, technological proficiency, data management, and employee performance to achieve organizational transformation and financial sustainability. Our Research Sector applies knowledge and expertise to further understand diabetes in the Arab population and improve health outcomes. By identifying gene variants, clinically relevant biomarkers, dietary components, and other risk factors, we strive to define new medical approaches to diabetes care. Our Medical Sector utilizes the highest standards of medical care and the latest research findings to tackle all aspects of diabetes prevention, treatment, and management.


Employees

201-500

Links